How I treat newly diagnosed chronic myeloid leukemia in 2015

C Gambacorti‐Passerini… - American journal of …, 2015 - Wiley Online Library
The initial treatment for chronic myeloid leukemia in chronic phase (CP‐CML) represents a
complex process, which includes a prompt and precise diagnosis, the choice among three …

How I treat newly diagnosed chronic myeloid leukemia in 2015

C Gambacorti-Passerini… - American journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
The initial treatment for chronic myeloid leukemia in chronic phase (CP-CML) represents a
complex process, which includes a prompt and precise diagnosis, the choice among three …

[PDF][PDF] CRITICAL REVIEW AJH AJH

C Gambacorti-Passerini, R Piazza - American Journal of Hematology, 2015 - academia.edu
Chronic myeloid leukemia (CML) treatment and prognosis were dramatically improved by
the development and clinical use of imatinib mesylate [1–3], the first ATP-competitive …

[PDF][PDF] Imatinib—A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015

MD Passerini, R Piazza - Am J Hematol, 2015 - researchgate.net
Imatinib mesylate changed the prognosis for chronic myeloid leukemia (CML) so
dramatically that patients with newly diagnosed CML starting treatment with imatinib now …

How I treat newly diagnosed chronic myeloid leukemia in 2015

C Gambacorti‐Passerini, R Piazza - American Journal of Hematology, 2015 - infona.pl
The initial treatment for chronic myeloid leukemia in chronic phase (CP‐CML) represents a
complex process, which includes a prompt and precise diagnosis, the choice among three …

How I treat newly diagnosed chronic myeloid leukemia in 2015

C GAMBACORTI PASSERINI, R Piazza - AMERICAN JOURNAL OF …, 2015 - boa.unimib.it
The initial treatment for chronic myeloid leukemia in chronic phase (CP-CML) represents a
complex process, which includes a prompt and precise diagnosis, the choice among three …

How I treat newly diagnosed chronic myeloid leukemia in 2015.

C Gambacorti-Passerini, R Piazza - American Journal of …, 2014 - europepmc.org
The initial treatment for chronic myeloid leukemia in chronic phase (CP-CML) represents a
complex process, which includes a prompt and precise diagnosis, the choice among three …

Imatinib—A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015

C Gambacorti-Passerini, R Piazza - JAMA Oncology, 2015 - jamanetwork.com
Imatinib mesylate changed the prognosis for chronic myeloid leukemia (CML) so
dramatically that patients with newly diagnosed CML starting treatment with imatinib now …

[引用][C] Imatinib--A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015

C Gambacorti-Passerini, R Piazza - JAMA oncology, 2015 - pubmed.ncbi.nlm.nih.gov
Imatinib--A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid
Leukemia in 2015 Imatinib--A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic …

[引用][C] Imatinib--A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015.

C Gambacorti-Passerini, R Piazza - JAMA Oncology, 2015 - europepmc.org
Imatinib--A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia
in 2015. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …